Previous Article | Next Article 
J Virol, May 1998, p. 4274-4280, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Role for the Sendai Virus P Protein Trimer in RNA
Synthesis
Joseph
Curran*
Department of Genetics and Microbiology,
University of Geneva Medical School, CH1211 Geneva, Switzerland
Received 16 September 1997/Accepted 10 February 1998
 |
ABSTRACT |
The SeV P protein is found as a homotrimer (P3) when it
is expressed in mammalian cells, and trimerization is mediated by a
predicted coiled-coil motif which maps within amino acids (aa) 344 to
411 (the BoxA region). The bacterially expressed protein also appears
to be trimeric, apparently precluding a role for phosphorylation in the
association of the P monomers. I have examined the role of P
trimerization both in the protein's interaction with the nucleocapsid
(N:RNA) template and in the protein's function on the template during
RNA synthesis. As with the results of earlier experiments
(32), I found that both the BoxA and BoxC (aa 479 to 568)
regions were required for stable binding of P to the N:RNA. Binding was
also observed with P proteins containing less than three BoxC regions,
suggesting that trimerization may be required to permit contacts
between multiple BoxC regions and the N:RNA. However, these
heterologous trimers failed to function in viral RNA synthesis,
indicating that the third C-terminal leg of the trimer plays an
essential role in P function on the template. We speculate that this
function may involve the movement of P (and possibly the polymerase
complex) on the template and the maintenance of processivity.
 |
INTRODUCTION |
The paramyxoviruses are enveloped
animal viruses containing a nonsegmented negative-stranded RNA genome.
Together with the rhabdoviruses and filoviruses, they constitute the
superfamily Mononegaloviridae. Sendai virus (SeV) is a
prototype member of the paramyxoviruses and has served as a model
system for examining the mechanisms that regulate viral genome
expression. The ca. 15-kb genome is never found as free RNA inside an
infected cell but rather is associated with the nucleocapsid protein (N
protein) in the form of a helical ribonucleoprotein complex, the
nucleocapsid (N:RNA). N:RNAs are 96% protein by mass (10)
and serve as the templates for mRNA synthesis and genome replication.
The SeV polymerase is a complex of two virally encoded proteins, the
phosphoprotein (P) and the large protein (L) (17, 31). Upon
entry into the cell, holonucleocapsids containing ca. 50 L and 200 P
proteins (25) can initiate a virus infection in the
cytoplasm by the sequential transcription of the six viral mRNAs
(so-called primary transcription). As viral protein products
accumulate, these same N:RNAs are used as templates for genome
replication, via the synthesis of an antigenome N:RNA intermediate
which is also assembled with N protein. Hence, the availability of
unassembled N (N°) protein is considered to be a crucial element in
regulating the switch between replication and transcription (reviewed
in reference 24).
Paramyxovirus P genes are polycistronic, expressing proteins from at
least two, and frequently all three, open reading frames (ORFs). The
SeV P protein (568 amino acids [aa]) is expressed from the largest
ORF on the P mRNA. In addition, a nested set of four C proteins (C', C,
Y1, and Y2) are translated from an ORF which overlaps the N terminus of
the P ORF (in the +1 frame) by a mechanism of ribosomal choice during
initiation (26). An internal V ORF (in the
1 phase) is
accessed via the programmed insertion of a G residue at position 1053 during mRNA synthesis (cotranscriptional editing), which results in a
ribosomal frameshift and the expression of V as a fusion protein with
the N terminus of P (23). This same region of P is also
found in another viral protein, called W, which is generated by the
addition of +2Gs at the editing site, a reading frame switch that fuses
only 2 aa to the N-terminal half of P (i.e., W is effectively the
N-terminal half of P). Of all these P gene products, only the P protein
is essential for genome amplification (see below). The C proteins are
promoter-specific inhibitors of RNA synthesis and exert this activity
indirectly, possibly through transient interactions with P or L protein
(2, 6, 20, 35). Likewise, the V and W proteins are negative
regulators of viral amplification, inhibiting replication but not
transcription in a dose-dependent manner (4).
The SeV P protein is the central component of the viral replication
machinery, forming (i) a complex with the L protein and (ii) a complex
with N°. The L protein is the catalytic component of the viral
polymerase (P-L). This complex serves to both stabilize the L protein
(8, 33) and place the polymerase complex (P-L) on the N:RNA
template via interactions with the exposed C-terminal tail of the
assembled N protein (L alone is unable to interact with the N:RNA)
(21, 27). The complex with N protein (P-N°) is the active
form of soluble N protein used during assembly. Formation of this
complex prevents nonspecific aggregation of the N protein, and
consequently, P can be viewed as a chaperone for N° (7).
Independently of stable complex formation with the L protein, P also
has an additional role to play in viral RNA synthesis. This function
involves, at least in part, the binding of additional copies of P to
the N:RNA template (3). These supplemental P proteins may
play a role during elongation (e.g., by enhancing the processivity of
the polymerase or by modulating the conformation of the coiled N:RNA
template and thereby facilitating reading of the bases).
Replication, which can be viewed as RNA synthesis plus concurrent
assembly, can be reconstituted in vitro by combining extracts in which
P-N (the assembly complex) and P-L (the polymerase complex) have been
separately coexpressed (19). This two-part system has served
to map domains on P involved in RNA synthesis and assembly (Fig.
1), and the results highlight the
multifunctional nature of the P protein. Domains specific for RNA
synthesis (interaction with the L protein and the N:RNA template) map
to the C-terminal half of the polypeptide (aa 344 to 568) (8,
9), whereas a domain involved in formation of a stable complex
with N°, and hence in nascent chain assembly, maps to aa 33 to 41 in
the N terminus (7). Indeed, the entire N-terminal half of
the P protein (aa 1 to 320) is dispensable for RNA synthesis
(3). Likewise, the region required for stable complex
formation with L (aa 412 to 445) is required for the RNA synthesis step
of replication (with L) but not for the assembly process (with N)
(8).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of the SeV P protein. The P
protein (568 aa) is shown as a rectangle, with the various functional
domains indicated by shaded boxes. Residues 33 to 41 are required for
chaperoning N° during the nascent chain assembly step of genome
replication. Two blocks within the C-terminal 40% of the protein (aa
344 to 411 and 479 to 568, previously designated segments A and C) are
involved in binding to N:RNA. Segment A is required for trimerization
(indicated as 3'mer), and only trimers bind to the template. Residues
412 to 445 represent the stable binding site for the L protein. The
bent arrow above the diagram indicates the site at which the alternate
C-terminal ORFs of the V and W proteins are fused to the N-terminal
half of P by mRNA editing.
|
|
The SeV P protein is found as a homotrimer (P3) when it is
expressed in mammalian cells. Computer analysis of 13 paramyxovirus P
proteins revealed a predicted coiled-coil region which may be aligned
throughout the entire virus subfamily, and it appears that this region
is sufficient for oligomerization (9). One exception is the
Newcastle disease virus P protein, but recent experiments in my lab
indicate that it too forms a stable homotrimer (32a),
indicating that trimerization is a general property of all the
paramyxovirus P proteins. In this paper, I examine both the role of
trimerization in the interaction between P protein and the N:RNA
template and its role in P function on the template during RNA
synthesis.
 |
MATERIALS AND METHODS |
Construction of subclones.
The wild-type P (Pwt) and P
deletion mutants used throughout this study were N-terminally tagged
with the influenza virus HA1 epitope (12), and such tagging
is indicated with a superscript "HA" before the protein
designation. A detailed description of the construction of the tagged
Pwt clone (pGEM-HAP) and the deletion mutants is to be
found in Curran et al. (7, 8). Throughout this paper, C- and
N-terminal P deletion mutants are indicated with the amino acids that
remain (e.g., P78-568) whereas internal deletion mutants
are indicated with the amino acids deleted (e.g.,
P
344-411).
Purification of bacterially expressed P protein.
An
N-terminally six-histidine (His6)-tagged P
(HisP) gene construct (the His6 plus an ATG
start codon was positioned just upstream of the authentic ATG start
codon of P) was inserted into the bacterial expression vector pT7-7
(pT7-7 HISP). Escherichia coli BL21 transformed
with this construct was grown in L broth supplemented with 0.3%
glucose at 37°C to an optical density at 600 nm of 0.7. Gene
expression was then induced by the addition of 1 mM IPTG
(isopropyl-
-D-thiogalactopyranoside), followed 90 min
later by the addition of rifampin (200 µg/ml). Incubation was then
continued for a further 4 h. Bacteria were pelleted and
resuspended in lysis buffer (20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 8 M urea). HisP was purified on a Talon metal affinity column
(Clontech) according to the manufacturer's instructions. The bound
protein was eluted in lysis buffer containing 150 mM imidazole. The
protein was renatured by a gradual removal of the urea (in 0.5 M steps)
by dialysis against 100 mM NaCl, 20 mM Tris-HCl (pH 8.45), 1 mM EDTA,
and 1% Nonidet P-40 (NP-40). The protein was concentrated by binding to a Hi-Trap Q column (Pharmacia) and elution in 300 mM NaCl plus 20 mM
Tris-HCl (pH 8.45).
Purification of His-tagged proteins from transfected mammalian
cells.
A549 cells infected with a vaccinia virus recombinant
expressing T7 polymerase (vTF7-3 [13]) were
transfected with plasmid pT7-7 HISP. Cytoplasmic extracts
were prepared in 20 mM Tris-HCl (pH 8.0)-100 mM NaCl-0.6% NP-40. The
His-tagged proteins were purified on a Talon metal affinity column
(Clontech) according to the manufacturer's instructions. Bound
proteins were eluted in 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 0.6%
NP-40 buffer containing 150 mM imidazole. They were then dialyzed
against RM salts (100 mM HEPES [pH 7.4], 50 mM NH4Cl, 7 mM KCl, 4.5 mM magnesium acetate, 1 mM dithiothreitol [DTT]).
N:RNA binding assay.
Binding of P and P deletion mutants to
the N:RNA was monitored essentially as outlined in reference
30). Briefly, cytoplasmic extracts prepared from
A549 cells transfected with the plasmids indicated in the figure
legends were mixed with 1 µg of SeV core N:RNA (isolated by
purification on linear CsCl gradients). After incubation on ice for 60 min, N:RNAs were recovered by pelleting through 50% glycerol-TNE (10 mM Tris-HCl [pH 7.4], 30 mM NaCl, 1 mM EDTA) at 16,000 × g for 1 h at 4°C. The presence of N:RNA and bound P
was confirmed by immunoblotting with anti-N monoclonal antibody and a
monoclonal antibody to an epitope of the influenza virus HA1 protein,
designated 12CA5 (12), herein referred to as anti-HA
monoclonal antibody. As a negative control, a duplicate assay was
performed in the absence of N:RNA.
In vitro RNA synthesis.
RNA synthesis in vitro was performed
essentially as described in reference 8 with the
modifications outlined in reference 3. N:RNA
nondefective templates were isolated from infected egg allantoic fluid
(strain Z) by banding twice on 20 to 40% CsCl gradients. Templates
were resuspended at a concentration of ca. 250 ng/µl in TE (10 mM
Tris [pH 7.4], 1 mM EDTA) containing 1 mM DTT-10% glycerol and
stored at
70°C.
To isolate the P-L complex, A549 cells (5-cm-diameter petri dish) were
transfected with 2.5 µg of pGEM-HAP and 1.0 µg of
pGEM-L. Cytoplasmic extracts were prepared by solubilizing the cells in
250 µl of lysis buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.4], 10 mM
EDTA, 0.6% NP-40), and P-L complexes were immunoprecipitated with 1 µl of anti-L monoclonal antibody. Antibody complexes were recovered
by the addition of 100 µl of a 50% suspension of protein A-Sepharose
beads (Pharmacia) equilibrated in RM salts. This mixture was then
incubated for a further hour at 4°C, after which the Sepharose beads
were recovered by pelleting and washed three times with RM salts. The
beads were then resuspended in 100 µl of transcription buffer (100 mM
HEPES [pH 7.4], 150 mM NH4Cl, 4.5 mM magnesium acetate, 1 mM DTT, 0.5 mM ATP-CTP-UTP, 40 U of creatine phosphokinase per ml, 1 mM
creatine phosphate). In vitro RNA synthesis was generally carried out
in 250-µl reaction mixtures containing 25 µl of the bead
suspension, 5 µl of the template, 100 µl of vaccinia virus-T7
(vac-T7)-infected A549 cell extract, 30 µCi of
[
-32P]GTP, 20 µg of actinomycin D per ml, and
purified P protein (see legend to Fig. 5) at 30°C for 3 h. After
the reaction, 500 µl of lysis buffer (150 mM NaCl, 50 mM Tris [pH
7.4], 10 mM EDTA, 0.6% NP-40) was added and the RNA was recovered by
pelleting through 5.7 M CsCl. Products were analyzed directly on 1.5%
agarose-HCHO gels.
Immunoblotting and antibodies.
Anti-HA was obtained from the
Berkeley Antibody Co. The monoclonal antibody N877 (29),
which recognizes an epitope near the C terminus of N, was kindly
provided by Claes Örvell, Stockholm, Sweden. The monoclonal
antibody to a C-terminal peptide of the L protein (11),
referred to as anti-L, was kindly provided by my laboratory. The anti-P
polyclonal antibody (PSDS) has already been described
(4). Proteins were detected by immunoblotting with an
enhanced chemiluminescence system (Amersham).
 |
RESULTS |
The bacterially expressed SeV P protein is trimeric.
HisP was expressed in E. coli BL21. The majority
of the protein was found to be insoluble (<10% of the protein
remained soluble when the bacteria were lysed by sonication in the
presence of 1% NP-40). The bacterial pellets were therefore
resuspended in 8 M urea, and after purification (see Materials and
Methods) the protein was renatured by a gradual removal of the
denaturant by dialysis in the presence of 1% NP-40 (0.5 M steps).
Failure to include nonionic detergent during renaturation resulted in
the precipitation of the protein in the dialysis sac. Both the soluble and renatured HisP proteins were then analyzed by
sedimentation, in parallel with cytoplasmic extracts from HeLa cells
transfected with the same plasmid clone. As shown in Fig.
2, all proteins gave similar
sedimentation profiles with a single peak in fraction 5. The
bacterially expressed SeV P protein is thus also probably trimeric,
even after denaturation and renaturation. The trimer appears to be the
most energetically favored form of the protein under normal salt
conditions and neutral pH.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Sedimentation analysis of bacterially expressed
HisP protein. E. coli BL21 transformed with
pT7-7 HISP was grown in L broth supplemented with 0.3%
glucose at 37°C to an optical density at 600 nm of 0.7. Gene
expression was then induced by the addition of 1 mM IPTG, followed 90 min later by the addition of rifampin (200 µg/ml). Incubation was
then continued for a further 4 h. Bacteria were pelleted and
resuspended in lysis buffer (20 mM Tris-HCl [pH 8.0], 100 mM NaCl)
containing either 1% NP-40 (native conditions) or 8 M urea (denaturing
conditions). HisP was purified and renatured as described
in Materials and Methods. These proteins were centrifuged on linear 5 to 20% glycerol gradients (40,000 rpm, 22 h, 4°C in a SW60
rotor; see reference 9) along with a cytoplasmic
extract prepared from vTF7-3-infected HeLa cells transfected with the
same plasmid clone. Gradients were fractionated, and aliquots from each
fraction were analyzed by immunoblotting with the anti-P1.180
monoclonal antibody with an enhanced chemiluminescence light detection
system. The amount of protein in each fraction was determined by
densitometry and plotted (sedimentation was from right to left). P1
refers to the position of HAP 344-411 (a
monomeric P protein [9]) sedimented on a parallel
gradient.
|
|
Interaction with the N:RNA.
Ryan and coworkers (32)
reported that two discontinuous regions of the P protein, namely BoxA
(aa 344 to 411) and BoxC (aa 479 to 568) (Fig. 1), were important for
N:RNA binding. These experiments were performed with proteins expressed
in reticulocyte lysates; therefore, I decided to test their
observations with proteins produced in the vac-T7 expression system. In
addition to the deleted proteins examined previously (
A and
C), I
also tested constructs in which the N-terminal chaperone domain for N° (aa 33 to 41) had been deleted (P78-568 and
P145-568). Apart from the monomeric
HAP
344-411 (
A), all the constructs tested
formed stable trimers, as estimated from their sedimentation on linear
glycerol gradients (9). Figure
3 confirms that both the BoxA and BoxC
regions are required for stable interaction with the N:RNA, whereas the
N-terminal chaperone region of P is dispensable for this property.
However, the region defined as BoxA also contains the coiled-coil motif required for P protein oligomerization (9). Therefore,
rather than regions BoxA and BoxC folding to form a single N:RNA
binding surface in a monomeric P protein (as suggested by Ryan and
coworkers [32]), trimerization may be required either
to permit contacts between multiple BoxC regions and the N:RNA or to
induce a conformational change in the BoxC region necessary for stable
P interaction with the N:RNA. I therefore decided to examine whether
P3 interaction with the N:RNA required three BoxC regions.
For this examination, I expressed independently HAP,
HAP1-445, and HAP1-538
and coexpressed HAP with HAP1-445,
HAP with HAP1-538, and
HAP1-445 with HAP1-538.
N:RNA binding assays were then performed, and the proteins present in
the pellet were visualized by immunoblotting with a combination of
anti-N and anti-HA monoclonal antibodies. Neither of the C-terminal deletion mutants bound to N:RNA, either when they were expressed alone
or when they were coexpressed. However, both deleted proteins were
detected in the pellet when each was coexpressed with HAP
(Fig. 4B). Both these deletion mutants
form homotrimers and can cooligomerize with HAP (7,
9), suggesting that mixed trimers containing only one or two BoxC
regions can still bind to N:RNA. Quantification of the blots showed
that the pellets contained ca. three times as much HAP as
HAP1-538 and ca. twice as much HAP
as HAP1-445, even though the levels of the
proteins in the cytoplasmic extracts were either equal (as with
HAP and HAP1-568) or the deleted
protein was in slight excess (as with HAP and
HAP1-445) (Fig. 4A). If the two proteins are
expressed at similar levels and one assumes that there is a random
assortment of the monomers, then the intracellular ratio of the
trimeric forms (
3 to
2
1 to
1
2 to
3, where
is
HAP and
is HAP
) is 1:3:3:1.
If one BoxC region within a heterotrimer is sufficient for stable N:RNA
binding (stable being defined as the ability of the protein to remain
bound after traversing a glycerol cushion), then the ratio of
HAP to HAP
in the pellet would
be 4:3, whereas if two BoxC regions are required, this ratio would be
3:1. Therefore, the ratio of proteins observed suggests that two BoxC
regions are required for stable binding of P3 to the N:RNA.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Binding of P to the N:RNA requires the BoxA and BoxC
regions but not the N° chaperone domain. A549 cells (5-cm-diameter
petri dish) infected with vTF7-3 were transfected with 2.5 µg of
either HAPwt (aa 1 to 568),
HAP78-568, HAP145-568,
HAP 344-411 ( A), or
HAP1-538 (these mutants are depicted
schematically above panel A). Cytoplasmic extracts were prepared in 250 µl of RM salts containing 1 mM DTT. (A) Cytoplasmic extract (50 µl)
was mixed with either 1 µg (5 µl) of core N:RNA (+) or 5 µl of TE
( ) and incubated on ice for 60 min. N:RNAs were recovered by
pelleting through 50% glycerol-TNE, and the presence of tagged P
protein in the pellet was confirmed by immunoblotting with an anti-HA
monoclonal antibody. (B) The steady-state levels of the tagged P
proteins present in the extracts were also evaluated by immunoblotting
with the anti-HA monoclonal antibody. The slower-migrating forms
represent a small fraction of the P trimer that remain intact under the
conditions of the sodium dodecyl sulfate-polyacrylamide gel (indicated
as P3). Note that in the mutant
HAP 344-411 ( A), no P3 band is
visible, consistent with this mutant being monomeric (9).
wt, wild type.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Mixed P trimers can bind to the N:RNA. (A) A549 cells
were transfected with HAPwt (568),
HAP1-538 (538), or
HAP1-445 (445) or doubly transfected with the
plasmid combinations indicated above the figure (these mutants are
depicted schematically above panel A). (A) Cytoplasmic extracts were
prepared in 250 µl of RM salts containing 1 mM DTT, and the
steady-state levels of the proteins expressed were analyzed by
immunoblotting with the anti-HA monoclonal antibody. (B) Cytoplasmic
extract (50 µl) was mixed with either 1 µg (5 µl) of core N:RNA
(+) or 5 µl of TE ( ) and incubated on ice for 60 min. N:RNAs were
recovered by pelleting through 50% glycerol-TNE, and the presence of
N protein and tagged P protein in the pellet was confirmed by
immunoblotting with a combination of anti-N and anti-HA monoclonal
antibodies.
|
|
Binding of mixed trimers is not sufficient for function.
To
determine whether a P3 protein containing only two
C-terminal regions (BoxC) was active in RNA synthesis, I tested whether mixed P trimers could substitute for Pwt in its supplemental function during transcription. This is technically more feasible than isolating P-L complexes containing mixed P trimers. A His6 tag was
fused to the C terminus of P1-445
(HisP1-445). The
HisP1-445 construct was coexpressed with Pwt
(nontagged) under conditions in which the Pwt protein was in
steady-state excess over the level of the truncated form, so that the
majority of the mixed trimers generated contained a single
HisP1-445. As a control, a His6 tag
was also fused to the N terminus of Pwt (HisP). Tagged
proteins were then selected from transfected cells with a talon
affinity column (see Materials and Methods), and aliquots of the
proteins eluted were analyzed by immunoblotting with a polyclonal
anti-P antiserum. The amounts of HisP homotrimer and
Pwt-HisP1-445 heterotrimer recovered from the
column were estimated by densitometric scanning of the immunoblot. The
nontagged Pwt protein bound to the talon column when it was coexpressed
with HisP1-445 but not when it was expressed
alone (data not shown), consistent with the formation of mixed trimers.
The relative ratio of the Pwt and HisP1-445
proteins recovered from the doubly transfected cell extract ± the
standard deviation was ca. 3.5:1 ± 0.4 (n = 4).
RNA synthesis was reconstituted by mixing nondefective N:RNA templates
and the immobilized P-L polymerase complex (purified from free P
protein by immunoselection with protein A-Sepharose beads coated with
an anti-L monoclonal antibody; see Materials and Methods and reference
3) with increasing amounts of either the purified
homo- or heterotrimer. In each reaction, 100 µl of mock-transfected
cell extract was also added, as this markedly stimulates viral RNA
transcription. De novo RNA synthesis was followed by the incorporation
of [
-32P]GTP, and the products were resolved on a
HCHO-agarose gel (Fig. 5A). As controls,
the immobilized polymerase complex and N:RNA template were mixed with
cell extracts from mock-, HisP-, and
HisP1-445-transfected cells (lanes 10 to 12, respectively). This analysis confirmed that the HisP
protein was active and that the HisP1-445
homotrimer was inactive in this supplemental function of P. Titration of the purified HisP homotrimer progressively stimulated
RNA synthesis (no plateau was observed), with the activity at the
highest concentration corresponding to 60% of the activity observed in
the HisP-transfected cell extract (Fig. 5B). In contrast,
only a weak stimulation of transcription was observed with the purified
heterotrimer (RNA synthesis was sixfold lower than that observed with
HisP at the highest concentration of protein tested).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
Mixed P trimers do not function in RNA transcription.
A549 cells were transfected with HisP or doubly transfected
with Pwt plus HisP1-445. Tagged proteins were
isolated on a Talon metal affinity column and dialyzed against RM salts
containing 1 mM DTT. The yields of homotrimer (HisP) and
mixed trimer (HisP1-445-Pwt) were estimated by
immunoblotting with a polyclonal anti-P antibody, and the final volumes
were adjusted such that the concentration of protein in each lane was
the same. (A) Cytoplasmic extracts from A549 cells (5-cm-diameter petri
dish) transfected with pGEM-HAP (2.5 µg) and pGEM-L (1 µg) were immunoprecipitated with an anti-L monoclonal antibody, and
immune complexes were recovered by the addition of protein A-Sepharose
beads. The beads were pelleted and washed three times with RM salts
containing 1 mM DTT before being resuspended in 100 µl of
transcription buffer. RNA synthesis was produced by mixing these P-L
antibody complexes (Ab-P/L) with nondefective core N:RNAs in either (i)
extracts from mock-transfected cells supplemented with no trimer (lane
1, -ve ctrl) or 25, 50, 100, and 140 µl of either the purified
HisP homotrimer (lanes 2 to 5, respectively) or the
HisP1-445-Pwt mixed trimer (lanes 6 to 9, respectively) or (ii) vTF7-3-infected cells mock transfected (lane 10, vacT7) or transfected with HisP (lane 11) or
HisP1-445 (lane 12) in the presence of
[32P]GTP (these combinations are represented
schematically in the upper diagram). Reactions products were pelleted
through 5.7 M CsCl and resolved on a 1.5% agarose-HCHO gel. (B) The
gel was quantitated on a phosphorimager and then plotted graphically.
(C) The purified His-tagged proteins were also tested in an N:RNA
binding assay as outlined in Fig. 3. Bound P protein was detected by
immunoblotting with an anti-P polyclonal antibody (PSDS)
with a light detection system, and the proteins in the blots were
quantitated with a densitometer. The results were then plotted
graphically (bound protein in the mixed trimer is the sum of Pwt and
HisP1-445).
|
|
A trivial explanation for the failure of the His-tagged heterotrimer to
stimulate transcription is that the presence of the histidine stretch
at the C terminus of P1-445 impeded interaction with the
template. To test this, I repeated the N:RNA binding assay. Both the
tagged homo- and heterotrimers bound the N:RNA template with similar
efficiencies (Fig. 5C). These experiments indicate
that although P trimers carrying less than three BoxC regions can
interact stably with the N:RNA, all three C-terminal domains are
required at least for the supplemental function of P in RNA synthesis.
 |
DISCUSSION |
In this paper, I have examined the role of SeV P trimerization in
the protein's interaction with the N:RNA template. Interaction with
the template required both the trimerization domain (BoxA) and the
C-terminal domain (BoxC). Ryan and coworkers (32) postulated that these two discontinuous regions of the P protein form a single surface that interacts with the N:RNA, thereby looping out the intervening BoxB region, which contains the L binding site. However, stable interaction with the N:RNA requires that a minimum of two BoxC
regions interact simultaneously with the exposed C-terminal tail of the
assembled N protein (1, 5, 18, 28), and this simultaneous
interaction is achieved through a trimeric P protein. The N-terminal
region of P involved in chaperoning N° is dispensable for N:RNA
binding, which is consistent with the demonstration that the entire
N-terminal half of P is not required for RNA synthesis (3).
Like the SeV P protein, the vesicular stomatitis virus (VSV) P protein
is found as an oligomer, possibly a trimer (14), although
there are clearly differences in the ways these structures form. The
VSV P protein has only a weak coiled-coil prediction within the
N-terminal 30 aa, and it appears that phosphorylation at Ser62 and
Thr64 facilitates protein multimerization (15, 34). Only
this multimeric form of the P protein is active in RNA synthesis, since
it is in this form that the protein interacts both with L and with the
N:RNA template (16, 34). The SeV P protein, on the other
hand, is found exclusively as a trimer, whether it is expressed in
mammalian, insect, or bacterial expression systems, which apparently
precludes a role for phosphorylation in the association of the P
monomers. This lack of phosphorylation is further supported by the
demonstration that N-terminal P deletion mutants lacking all the known
sites for P protein phosphorylation are also trimeric and active in RNA
synthesis (3). Even when made in reticulocyte lysates,
conditions in which the concentration of the expressed protein is very
low, SeV P is found only as a trimer. The inherent high stability of
the trimer is further highlighted by the fact that the insertion of Pro
(a helix-destabilizing amino acid) into the middle of the predicted
coiled-coil A2 region (after aa 400) failed to perturb either P trimer
formation or P function in RNA synthesis (data not shown). Furthermore,
I have been unable to demonstrate subunit exchange within the trimer
under the conditions of RNA synthesis (conditions under which exchange
rates are very high for the VSV multimer [15]).
Therefore, the association constant for SeV P trimerization is clearly
much lower than that observed for VSV, and once formed, the
P3 appears to be stable.
Why a trimer? At least in part, an explanation can be found by
considering P binding to the N:RNA. Monomeric P proteins containing the
BoxC region do not bind, whereas trimers containing two such regions
appear to interact stably with the N:RNA (Fig. 4B). The three BoxC
regions may form a binding site that is altered when one region is
deleted, leading in turn to an incorrect (and hence inactive)
interaction with the N:RNA. Alternatively, as already suggested for the
VSV P protein (16), each BoxC region may interact weakly
with the tail of a single N monomer, this interaction then being
stabilized by the multivalency of the P protein. Assuming that only two
BoxC regions are required for binding, what then is the function of the
third leg of the trimer? One possibility is that it interacts with a
factor(s) important for RNA synthesis, e.g., a host cell factor, the
polymerase L protein, or one of the viral nonstructural proteins that
are known to modulate genome expression (the V and C proteins).
Alternatively, the nonbound third leg may be involved in the
processivity of the P protein on the template. In such a model, P
is envisaged to "walk" on the template via the simultaneous
breaking and reforming of subunit-template contacts (which is
easily achieved, as each subunit interaction is weak; therefore, the
energy barrier is quite low and the net reaction is isoenergetic) such
that two "feet" of the trimer continuously engage the template,
somewhat like a cartwheel (Fig. 6), to
ensure processivity. The model explains why mixed trimers carrying only two BoxC regions appear to bind normally to N:RNA but do not function in RNA synthesis. Although in this study I have examined only the
activity of the supplemental P protein in RNA synthesis, I assume that
the P protein of the polymerase complex interacts with, and functions
on the N:RNA, in a similar fashion. Indeed, all mutations that affect
the supplemental function of P also affect its function in the
polymerase complex, suggesting that the two activities involve similar
protein domains (e.g., there may be an exchange of the template-bound P
and the P of the polymerase complex during RNA synthesis
[3]). Thus, the trimer permits the formation of
multiple weak contacts, which in turn facilitates the modulation of
protein-protein interactions. Such a characteristic is ideally suited
for a multifunctional protein such as P, which must continuously
modulate its interaction with other viral proteins.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 6.
A model for P trimer function on the N:RNA template.
Stable interaction between P3 and N:RNA involves contacts
between two BoxC regions (depicted as ellipses at the ends of trimeric
P proteins [bent lines]) and the exposed C-terminal tails of two
assembled N proteins (depicted as rectangles on circles, the circles
representing the structural core of N). The third leg of P3
remains unbound and free. The trimer is visualized as moving along the
N:RNA (indicated by arrows) by simultaneously making and breaking P-N
contacts such that two feet of the trimer continuously engage the
template to ensure processivity by cartwheeling. The model also
proposes that binding of P (and possibly also P-L) opens the N:RNA
structure so that the polymerase can interact with the bases
(22).
|
|
 |
ACKNOWLEDGMENTS |
I acknowledge Jean-Baptist Marq for excellent technical
assistance and Dan Kolakofsky and Laurent Roux for their constructive criticisms of both the work and the manuscript.
The work was supported by the Swiss National Science Foundation.
 |
FOOTNOTES |
*
Mailing address: Department of Genetics and
Microbiology, University of Geneva Medical School, 9 avenue de Champel,
CH1211 Geneva, Switzerland. Phone: (41 22) 702 5727. Fax: (41 22) 702 5702. E-mail: curran{at}cmu.unige.ch.
 |
REFERENCES |
| 1.
|
Buchholz, C. J.,
C. Retzler,
E. Horst,
H. E. Homann, and W. J. Neubert.
1994.
The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between the phosphoprotein and nucleocapsid like particles.
Virology
204:770-776[Medline].
|
| 2.
|
Cadd, T.,
D. Garcin,
C. Tapparel,
M. Itoh,
M. Homma,
L. Roux,
J. Curran, and D. Kolakofsky.
1996.
The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion.
J. Virol.
70:5067-5074[Abstract/Free Full Text].
|
| 3.
|
Curran, J.
1996.
Reexamination of the Sendai virus P protein domains required for RNA synthesis. A possible supplemental role for the P protein.
Virology
221:130-140[Medline].
|
| 4.
|
Curran, J.,
R. Boeck, and D. Kolakofsky.
1991.
The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing.
EMBO J.
10:3079-3085[Medline].
|
| 5.
|
Curran, J.,
H. Homann,
C. Buchholz,
S. Rochat,
W. Neubert, and D. Kolakofsky.
1993.
The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation.
J. Virol.
67:4358-4364[Abstract/Free Full Text].
|
| 6.
|
Curran, J.,
J.-B. Marq, and D. Kolakofsky.
1992.
The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis.
Virology
189:647-656[Medline].
|
| 7.
|
Curran, J.,
J.-B. Marq, and D. Kolakofsky.
1995.
An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication.
J. Virol.
69:849-855[Abstract].
|
| 8.
|
Curran, J.,
T. Pelet, and D. Kolakofsky.
1994.
An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation.
Virology
202:875-884[Medline].
|
| 9.
|
Curran, J.,
R. Boeck,
N. Lin-Marq,
A. Lupas, and D. Kolakofsky.
1995.
Paramyxovirus phosphoproteins form homo-trimers as determined by an epitope dilution assay, via predicted coiled coils.
Virology
214:139-149[Medline].
|
| 10.
|
Egelman, E. H.,
S. S. Wu,
M. Amrein,
A. Portner, and K. Murti.
1989.
The Sendai virus nucleocapsid exists in at least four different helical states.
J. Virol.
63:2233-2243[Abstract/Free Full Text].
|
| 11.
|
Einberger, H.,
P. H. Mertz,
P. H. Hofschneider, and W. J. Neubert.
1990.
Purification, renaturation, and reconstituted protein kinase activity of the Sendai virus large (L) protein: L protein phosphorylates the NP and P proteins in vitro.
J. Virol.
64:4274-4280[Abstract/Free Full Text].
|
| 12.
|
Field, J.,
J.-I. Nikawa,
D. Broeck,
B. MacDonald,
L. Rodgers,
I. A. Wilson,
R. A. Lerner, and M. Wigler.
1988.
Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method.
Mol. Cell. Biol.
8:2159-2165[Abstract/Free Full Text].
|
| 13.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 14.
|
Gao, Y.,
N. J. Greenfield,
D. Z. Cleverley, and J. Lenard.
1996.
The transcriptional form of the phosphoprotein of vesicular stomatitis virus is a trimer: structure and stability.
Biochemistry
35:14569-14573[Medline].
|
| 15.
|
Gao, Y., and J. Lenard.
1995.
Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase-II.
EMBO J.
14:1240-1247[Medline].
|
| 16.
|
Gao, Y., and J. Lenard.
1995.
Cooperative binding of multimeric phosphoprotein (P) of vesicular stomatitis virus to polymerase (L) and template: pathways of assembly.
J. Virol.
69:7718-7723[Abstract].
|
| 17.
|
Hamagushi, M.,
T. Yoshida,
K. Nishikawa,
H. Naruse, and Y. Nagai.
1983.
Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex.
Virology
128:105-117[Medline].
|
| 18.
|
Heggeness, M. H.,
A. Scheid, and P. W. Choppin.
1981.
The relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide.
Virology
114:555-562[Medline].
|
| 19.
|
Horikami, S. M.,
J. Curran,
D. Kolakofsky, and S. A. Moyer.
1992.
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering genome replication in vitro.
J. Virol.
66:4901-4908[Abstract/Free Full Text].
|
| 20.
|
Horikami, S. M.,
R. E. Hector,
S. Smallwood, and S. A. Moyer.
1997.
The Sendai virus C protein binds L polymerase protein to inhibit viral RNA synthesis.
Virology
235:261-270[Medline].
|
| 21.
|
Horikami, S. M., and S. A. Moyer.
1995.
Alternative amino acids at a single site in the Sendai virus L protein produce multiple defects in RNA synthesis in vitro.
Virology
211:577-582[Medline].
|
| 22.
|
Hudson, L. D.,
C. Condra, and R. A. Lazzarini.
1986.
Cloning and expression of a viral phosphoprotein: structure suggests vesicular stomatitis virus NS may function by mimicking an RNA template.
J. Gen. Virol.
67:1571-1579[Abstract/Free Full Text].
|
| 23.
|
Kolakofsky, D.,
J. Curran,
T. Pelet, and J.-P. Jacques.
1993.
Paramyxovirus P gene mRNA editing, p. 105-123.
In
R. Benne (ed.), RNA editing. Ellis Horwood, Chichester, England.
|
| 24.
|
Lamb, R. A., and D. Kolakofsky.
1996.
Paramyxoviridae: the viruses and their application, p. 1177-1204.
In
B. N. Fields, et al. (ed.), Fields virology. Raven Press, New York, N.Y.
|
| 25.
|
Lamb, R. A.,
B. W. Mahy, and P. W. Choppin.
1976.
The synthesis of Sendai virus polypeptides in infected cells.
Virology
69:116-131[Medline].
|
| 26.
| Latorre, P., D. Kolakofsky, and J. Curran. The
Sendai virus Y proteins are initiated by a ribosomal shunt. Submitted
for publication.
|
| 27.
|
Mellon, M. G., and S. U. Emerson.
1978.
Rebinding of transcriptase components (L and NS) proteins to the nucleocapsid template of vesicular stomatitis virus.
J. Virol.
27:560-567[Abstract/Free Full Text].
|
| 28.
|
Mountcastle, W. E.,
R. W. Compans,
H. Lackland, and P. W. Choppin.
1974.
Proteolytic cleavage of subunits of the nucleocapsid of the paramyxovirus simian virus 5.
J. Virol.
14:1253-1261[Abstract/Free Full Text].
|
| 29.
|
Orvell, C., and M. Grandien.
1982.
The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus.
J. Immunol.
129:2779-2787[Medline].
|
| 30.
|
Pelet, T.,
J.-B. Marq,
Y. Sakai,
S. Wakao,
H. Gotoh, and J. Curran.
1996.
Rescue of Sendai virus cDNA templates with cDNA clones expressing parainfluenza virus type 3 N, P and L clones.
J. Gen. Virol.
77:2465-2469[Abstract/Free Full Text].
|
| 31.
|
Portner, A.,
K. G. Murti,
E. M. Morgan, and D. W. Kingsbury.
1988.
Antibodies against Sendai virus L protein: distribution of the protein in nucleocapsids revealed by immunoelectron microscopy.
Virology
163:236-239[Medline].
|
| 32.
|
Ryan, K. W.,
E. M. Morgan, and A. Portner.
1991.
Two noncontiguous regions of Sendai virus P protein combine to form a single nucleocapsid binding domain.
Virology
180:126-134[Medline].
|
| 32a.
| Simonet, V., and J. Curran. The NDV P protein forms
a stable homotrimer and oligomerization appears necessary for template
binding. Submitted for publication.
|
| 33.
|
Smallwood, S.,
K. W. Ryan, and S. A. Moyer.
1994.
Deletion analysis defines a carboxy-proximal region of the Sendai virus P protein that binds to the polymerase L protein.
Virology
202:154-163[Medline].
|
| 34.
|
Spadafora, D.,
D. M. Canter,
R. L. Jackson, and J. Perrault.
1996.
Constitutive phosphorylation of the vesicular stomatitis virus P protein modulates complex formation but is not essential for transcription or replication.
J. Virol.
70:4538-4548[Abstract].
|
| 35.
|
Tapparel, C.,
S. Hausmann,
T. Pelet,
J. Curran,
D. Kolakofsky, and L. Roux.
1997.
Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins.
J. Virol.
71:9588-9599[Abstract].
|
J Virol, May 1998, p. 4274-4280, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Timani, K. A., Sun, D., Sun, M., Keim, C., Lin, Y., Schmitt, P. T., Schmitt, A. P., He, B.
(2008). A Single Amino Acid Residue Change in the P Protein of Parainfluenza Virus 5 Elevates Viral Gene Expression. J. Virol.
82: 9123-9133
[Abstract]
[Full Text]
-
Llorente, M. T., Garcia-Barreno, B., Calero, M., Camafeita, E., Lopez, J. A., Longhi, S., Ferron, F., Varela, P. F., Melero, J. A.
(2006). Structural analysis of the human respiratory syncytial virus phosphoprotein: characterization of an {alpha}-helical domain involved in oligomerization. J. Gen. Virol.
87: 159-169
[Abstract]
[Full Text]
-
Moller, P., Pariente, N., Klenk, H.-D., Becker, S.
(2005). Homo-Oligomerization of Marburgvirus VP35 Is Essential for Its Function in Replication and Transcription. J. Virol.
79: 14876-14886
[Abstract]
[Full Text]
-
Bernado, P., Blanchard, L., Timmins, P., Marion, D., Ruigrok, R. W. H., Blackledge, M.
(2005). A structural model for unfolded proteins from residual dipolar couplings and small-angle x-ray scattering. Proc. Natl. Acad. Sci. USA
102: 17002-17007
[Abstract]
[Full Text]
-
Schneider, U., Blechschmidt, K., Schwemmle, M., Staeheli, P.
(2004). Overlap of Interaction Domains Indicates a Central Role of the P Protein in Assembly and Regulation of the Borna Disease Virus Polymerase Complex. J. Biol. Chem.
279: 55290-55296
[Abstract]
[Full Text]
-
Kingston, R. L., Baase, W. A., Gay, L. S.
(2004). Characterization of Nucleocapsid Binding by the Measles Virus and Mumps Virus Phosphoproteins. J. Virol.
78: 8630-8640
[Abstract]
[Full Text]
-
Chan, Y. P., Koh, C. L., Lam, S. K., Wang, L.-F.
(2004). Mapping of domains responsible for nucleocapsid protein-phosphoprotein interaction of henipaviruses. J. Gen. Virol.
85: 1675-1684
[Abstract]
[Full Text]
-
Johansson, K., Bourhis, J.-M., Campanacci, V., Cambillau, C., Canard, B., Longhi, S.
(2003). Crystal Structure of the Measles Virus Phosphoprotein Domain Responsible for the Induced Folding of the C-terminal Domain of the Nucleoprotein. J. Biol. Chem.
278: 44567-44573
[Abstract]
[Full Text]
-
Longhi, S., Receveur-Brechot, V., Karlin, D., Johansson, K., Darbon, H., Bhella, D., Yeo, R., Finet, S., Canard, B.
(2003). The C-terminal Domain of the Measles Virus Nucleoprotein Is Intrinsically Disordered and Folds upon Binding to the C-terminal Moiety of the Phosphoprotein. J. Biol. Chem.
278: 18638-18648
[Abstract]
[Full Text]
-
Henrickson, K. J.
(2003). Parainfluenza Viruses. Clin. Microbiol. Rev.
16: 242-264
[Abstract]
[Full Text]
-
de Breyne, S., Simonet, V., Pelet, T., Curran, J.
(2003). Identification of a cis-acting element required for shunt-mediated translational initiation of the Sendai virus Y proteins. Nucleic Acids Res
31: 608-618
[Abstract]
[Full Text]
-
Tuckis, J., Smallwood, S., Feller, J. A., Moyer, S. A.
(2002). The C-Terminal 88 Amino Acids of the Sendai Virus P Protein Have Multiple Functions Separable by Mutation. J. Virol.
76: 68-77
[Abstract]
[Full Text]
-
Gubbay, O., Curran, J., Kolakofsky, D.
(2001). Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity. J. Gen. Virol.
82: 2895-2903
[Abstract]
[Full Text]
-
Huang, C., Kiyotani, K., Fujii, Y., Fukuhara, N., Kato, A., Nagai, Y., Yoshida, T., Sakaguchi, T.
(2000). Involvement of the Zinc-Binding Capacity of Sendai Virus V Protein in Viral Pathogenesis. J. Virol.
74: 7834-7841
[Abstract]
[Full Text]
-
De, B. P., Hoffman, M. A., Choudhary, S., Huntley, C. C., Banerjee, A. K.
(2000). Role of NH2- and COOH-Terminal Domains of the P Protein of Human Parainfluenza Virus Type 3 in Transcription and Replication. J. Virol.
74: 5886-5895
[Abstract]
[Full Text]
-
Bowman, M. C., Smallwood, S., Moyer, S. A.
(1999). Dissection of Individual Functions of the Sendai Virus Phosphoprotein in Transcription. J. Virol.
73: 6474-6483
[Abstract]
[Full Text]